Diagnos Inc (ADK) - Total Liabilities
Based on the latest financial reports, Diagnos Inc (ADK) has total liabilities worth CA$2.71 Million CAD (≈ $1.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Diagnos Inc generate cash to assess how effectively this company generates cash.
Diagnos Inc - Total Liabilities Trend (2002–2025)
This chart illustrates how Diagnos Inc's total liabilities have evolved over time, based on quarterly financial data. Check ADK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Diagnos Inc Competitors by Total Liabilities
The table below lists competitors of Diagnos Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fondia Oyj
HE:FONDIA
|
Finland | €4.19 Million |
|
Kadestone Capital Corp
V:KDSX
|
Canada | CA$12.11 Million |
|
Otto Energy Ltd
AU:OEL
|
Australia | AU$11.15 Million |
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
USA | $22.69 Million |
|
Intersport Polska S.A.
WAR:IPO
|
Poland | zł210.92 Million |
|
Lancashire Holdings Ltd
LSE:LRE
|
UK | GBX3.04 Billion |
|
OXE Marine AB
ST:OXE
|
Sweden | Skr163.98 Million |
|
PeterLabs Holdings Bhd
KLSE:0171
|
Malaysia | RM21.70 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down Diagnos Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Diagnos Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Diagnos Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Diagnos Inc (2002–2025)
The table below shows the annual total liabilities of Diagnos Inc from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | CA$3.40 Million ≈ $2.46 Million |
-8.41% |
| 2024-03-31 | CA$3.72 Million ≈ $2.69 Million |
+34.08% |
| 2023-03-31 | CA$2.77 Million ≈ $2.00 Million |
+67.44% |
| 2022-03-31 | CA$1.66 Million ≈ $1.20 Million |
+102.29% |
| 2021-03-31 | CA$818.19K ≈ $591.87K |
+33.09% |
| 2020-03-31 | CA$614.78K ≈ $444.72K |
-90.23% |
| 2019-03-31 | CA$6.29 Million ≈ $4.55 Million |
+21.87% |
| 2018-03-31 | CA$5.16 Million ≈ $3.73 Million |
-25.03% |
| 2017-03-31 | CA$6.88 Million ≈ $4.98 Million |
+55.77% |
| 2016-03-31 | CA$4.42 Million ≈ $3.20 Million |
+216.34% |
| 2015-03-31 | CA$1.40 Million ≈ $1.01 Million |
+13.50% |
| 2014-03-31 | CA$1.23 Million ≈ $890.47K |
+158.71% |
| 2013-03-31 | CA$475.81K ≈ $344.19K |
+54.40% |
| 2012-03-31 | CA$308.16K ≈ $222.92K |
-7.07% |
| 2011-03-31 | CA$331.59K ≈ $239.87K |
+13.62% |
| 2010-03-31 | CA$291.84K ≈ $211.11K |
+15.49% |
| 2009-03-31 | CA$252.70K ≈ $182.80K |
-62.04% |
| 2008-03-31 | CA$665.70K ≈ $481.56K |
+269.71% |
| 2007-03-31 | CA$180.06K ≈ $130.25K |
+5.55% |
| 2006-03-31 | CA$170.59K ≈ $123.40K |
-20.71% |
| 2005-03-31 | CA$215.16K ≈ $155.64K |
-74.41% |
| 2004-03-31 | CA$840.66K ≈ $608.12K |
+63.08% |
| 2003-03-31 | CA$515.49K ≈ $372.90K |
-23.36% |
| 2002-03-31 | CA$672.62K ≈ $486.56K |
-- |
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more